Morgan Stanley analyst Erin Wright raised the firm’s price target on UnitedHealth (UNH) to $664 from $610 and keeps an Overweight rating on the shares. While policy will be “front and center” with varying degrees of exposure, or lack there of, across the Healthcare Services and Technology space, the focus will also be on indications of underlying utilization trends across MCOs, distributors, providers, labs, animal and dental into Q1, the analyst tells investors in a preview for the group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target raised to $703 from $697 at Bernstein
- Is UNH a Buy, Before Earnings?
- Is UnitedHealth (UNH) a Good Stock to Buy before Earnings?
- Person in custody after intruder reported on UnitedHealthcare campus, KSTP says
- Options Volatility and Implied Earnings Moves This Week, April 14 – April 17, 2025